Moneycontrol PRO
HomeNewsBusinessFor future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla

For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla

"In 10-14 days, Covovax can be available on CoWin at about Rs 900 plus tax," the SII chief executive said.

April 08, 2022 / 17:09 IST
SII CEO Adar Poonawalla. | Illustration: MoneyControl

SII CEO Adar Poonawalla. | Illustration: MoneyControl

With a vast section of the adult population being inoculated and the pace of vaccination declining in most parts of the country, Serum Institute of India (SII) chief executive officer Adar Poonawalla on April 8 said "free replacement" would be provided to hospitals, in case of future orders, if the vaccine expires.

"Everyone is accurate in pointing out that there is COVID fatigue and vaccine fatigue," Poonawalla told CNBC TV18, adding that taking this into consideration, SII is introducing the free replacement policy.

"No hospital should ever be in a position to throw away vaccine...For future orders, Serum will provide free replacement to hospitals in case a Serum vaccine expires," he said.

SII is currently producing two COVID-19 vaccines for mass usage in India - Covishield and Covovax. The former, which is the same as the Oxford-AstraZeneca vaccine, has been used for inoculating over 90 percent of the country's vaccinated population.

Covovax, which is the SII-produced version of the Novovax vaccine developed in the US, received regulatory nod last month for use on children aged above 12.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Both the vaccines have a shelf life of nine months, provided that the vials are safely stored at a temperature ranging from 2 to 8 degree celsius.

"In 10-14 days, Covovax can be available on CoWin at about Rs 900 plus tax," Poonawalla said, noting that the end user will have to pay price as mentioned on the application. The vaccine will be distributed to registered clinics and hospitals, he added.

For Covishield, SII will give a "heavy discount", Poonawalla said, adding that the vaccine will be sold to hospitals "below Rs 600 per dose".

"We are going to make the terms easy and equitable...My team is in touch with all private hospitals," Poonawalla added.

On the Centre's decision to allow a third vaccine dose for all adults from April 10, the Serum chief executive said it will be a "huge relief for all those who wanted to have a booster as precautionary measure or for travel."

Moneycontrol News
first published: Apr 8, 2022 05:09 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347